Urinary Retention Associated with Quetiapine Use

High-Risk Populations

Elderly patients face substantially elevated risk of urinary retention due to age-related bladder dysfunction, particularly when using quetiapine with other anticholinergic medications or having pre-existing conditions such as benign prostatic hyperplasia 1
The European Society of Cardiology recommends caution when using quetiapine in elderly patients due to the increased risk of urinary retention associated with age-related bladder dysfunction 1

Before initiating quetiapine, assess for symptoms of obstructive urinary flow, especially in elderly patients, as recommended by the Mayo Clinic 2

The European Heart Journal warns against combining quetiapine with other anticholinergic medications, such as anticholinergic respiratory agents, due to the substantially increased risk of urinary retention 1
The Mayo Clinic Proceedings advises avoiding the combination of quetiapine with tricyclic antidepressants, antimuscarinics for overactive bladder, and other antipsychotics with anticholinergic properties to minimize the risk of urinary retention 2

The Journal of Clinical Oncology suggests using the lowest effective dose of quetiapine in at-risk patients and considering alpha-adrenergic blockers like tamsulosin prophylactically to reduce the risk of urinary retention 3

Anticholinergic medications, such as antipsychotics, antidepressants, and antimuscarinics for overactive bladder, directly impair detrusor contractility and should be used with caution in patients with a history of urinary retention, as reported by The American Urological Association 4, 5
Antimuscarinic medications for overactive bladder carry specific warnings about urinary retention risk, ranging from 2.6-54% in some studies, and require careful patient counseling, according to The American Urological Association 4, 5, 6

The American Geriatrics Society warns that antipsychotics as a class can cause urinary retention, but emphasizes this risk is primarily driven by anticholinergic properties, with typical antipsychotics and highly anticholinergic agents posing the highest risk 7
The addition of antimuscarinic bladder medications to treat overactive bladder symptoms in patients on antipsychotics with anticholinergic properties, such as quetiapine, worsens retention risk dramatically, as noted by the Mayo Clinic Proceedings 8
Avoid prolonged indwelling catheterization if retention occurs, as intermittent catheterization is preferred to reduce infection risk, according to Circulation 9

When managing urinary retention, it is crucial to immediately exclude spinal cord compression and review and discontinue all medications with anticholinergic effects beyond the antipsychotic, then perform bladder catheterization, with intermittent catheterization preferred over indwelling, as suggested by Circulation 9